Introducing Menopause Hormone Therapy
Menopause hormone therapy (MHT) is a new term for what used to be called hormone replacement therapy or HRT. If you’ve never heard about menopause hormone therapy, it’s worth remembering that the change of name
Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993
For visual reference only; actual product may vary
US Name:
Stiolto
Alternative Names:
Spiolto Respimat (60 puffs)
Active Ingredients:
Olodaterol / Tiotropium
Brand Manufacturer:
Boehringer
Manufacturer Location:
Germany
Click here to view Product Insert
Click here to view Product Insert
For visual reference only; actual product may vary
Stiolto Respimat is a daily prescription inhaler for the long-term management of chronic obstructive pulmonary disease (COPD). It combines two bronchodilators, olodaterol and tiotropium, to help relax airway muscles. This action improves airflow, making it easier to breathe for 24 hours.
| Spiolto Respimat (60 puffs) Brand | 2.5mcg 1 Inhaler |
-
|
Our price: $120.00 |
Stiolto is a long-term maintenance inhaler used once a day to manage chronic obstructive pulmonary disease (COPD). It is a combination medication containing two active ingredients. These ingredients work together to make breathing easier. Stiolto helps control symptoms like wheezing, coughing, and shortness of breath. It is important to note this is not a rescue inhaler. It should not be used for sudden breathing problems. The medication comes in a device called a Respimat inhaler.
Stiolto works by combining two medicines that help relax the muscles around the airways in your lungs. The first ingredient, tiotropium, is a long-acting muscarinic antagonist (LAMA). It blocks signals that cause airway muscles to tighten. The second, olodaterol, is a long-acting beta2-agonist (LABA). It stimulates receptors that help these same muscles relax. This dual action opens the airways wider for a longer time. This allows for improved airflow and easier breathing over a 24-hour period.
Stiolto is for adults who have been diagnosed with chronic obstructive pulmonary disease (COPD). This includes people with emphysema or chronic bronchitis. It is prescribed for patients who need a long-term maintenance treatment. This medication helps manage daily symptoms and reduces the likelihood of flare-ups (exacerbations). Stiolto is not intended for treating asthma. It is also not suitable for patients under 18 years old. Your doctor will determine if this is the right medication for your condition.
Stiolto is typically administered as two puffs from the Respimat inhaler once every 24 hours. You should take your dose at the same time each day to maintain its effect. It is critical to follow the specific instructions provided by your doctor and the product leaflet. Do not change your dose without medical advice. Before the first use, you must prime the inhaler. The device includes a dose indicator to show how many puffs are left. Do not exceed the recommended daily dose.
Stiolto can cause side effects, although not everyone will experience them. Most side effects are mild and may go away with time. The most common effects include a runny nose, cough, and back pain. Some people may also experience a dry mouth or dizziness. You should always be aware of the potential for more serious adverse effects.
If you experience any of the following, seek medical help immediately:
IsraelPharm provides a reliable and affordable way to purchase your prescription Stiolto Respimat inhaler online. We are committed to providing access to genuine brand-name medications sourced from a licensed and regulated supply chain. Our platform makes ordering simple and convenient. Your medication is delivered directly to your door. Our customer care team is available to help with your orders and answer any questions. We ensure a secure and private purchasing experience. This allows you to manage your health with confidence and peace of mind from a trusted international pharmacy.
Some patients may experience side effects when using Stiolto. Common side effects can include:
While less common, serious side effects can occur. Stop using Stiolto and contact your doctor immediately if you experience:
This is not a complete list of all possible side effects. Always read the patient information leaflet.
Stiolto is indicated for the long-term, once-daily maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by helping to open the airways in your lungs to allow for better airflow, making breathing easier. Stiolto helps reduce COPD symptoms and minimize their impact on daily life.
Stiolto Respimat is a prescription maintenance inhaler used once daily for the long-term treatment of chronic obstructive pulmonary disease (COPD). It helps manage symptoms like shortness of breath, wheezing, and coughing associated with chronic bronchitis and emphysema. Stiolto is not a rescue inhaler and should not be used for sudden breathing problems. Its goal is to improve lung function and quality of life.
Stiolto begins to work within about 5 minutes of inhalation to help open up the airways. While some improvement in breathing may be felt quickly, its main benefit comes from consistent daily use. The full effect of Stiolto Respimat as a maintenance therapy builds over time. It provides a steady, 24-hour improvement in lung function to help control symptoms throughout the day and night.
Stiolto is not a steroid. It is a combination of two different types of bronchodilators: tiotropium and olodaterol. Tiotropium is a long-acting muscarinic antagonist (LAMA), and olodaterol is a long-acting beta2-agonist (LABA). These medicines work by relaxing the muscles around the airways in the lungs. This action helps to keep the airways open, making it easier to breathe.
Stiolto should not be used for a sudden breathing attack, as it is a long-term maintenance medication. It does not work quickly enough to relieve acute symptoms. For sudden breathing problems, you should use a short-acting rescue inhaler as prescribed by your doctor. Always have your rescue inhaler with you. If your breathing problems worsen, contact your doctor immediately.
The standard dosage for Stiolto Respimat is two puffs inhaled once a day, every day. It is important to take the doses at the same time each day to maintain an even level of medication in your system. You should not take more than the prescribed two puffs within a 24-hour period. Always follow your doctor's instructions for the correct dosage and administration.
If you miss a dose of Stiolto, you should take it as soon as you remember on that same day. However, do not take more than one dose (two puffs) in 24 hours. Simply take your next scheduled dose at your regular time the following day. Do not double up on doses to make up for the missed one, as this can increase the risk of side effects.
Stiolto can be used with other inhalers, but you must tell your doctor about all the medications you use. It is especially important not to use Stiolto with other medicines that contain a long-acting beta2-agonist (LABA) or a long-acting muscarinic antagonist (LAMA). Your doctor will guide you on how to safely use it with a rescue inhaler or other prescribed respiratory medicines.
Your Stiolto Respimat inhaler should be stored at room temperature, away from direct sunlight, heat, and moisture. Do not freeze the inhaler. Keep the cap closed when not in use to keep the mouthpiece clean. Once the cartridge is inserted into the inhaler, it should be discarded three months after that date, even if there is still medication inside it.
Stiolto is not commonly associated with weight gain. Clinical studies for Stiolto Respimat have not listed weight gain as a typical side effect. While some other medications for respiratory conditions, like oral corticosteroids, can cause weight gain, this is not a known effect of Stiolto's active ingredients. If you experience unexpected weight changes, you should discuss them with your doctor to identify the cause.
Drinking alcohol in moderation is generally not expected to interact with Stiolto. However, excessive alcohol use can sometimes worsen medical conditions or increase the risk of side effects from medications. Alcohol can also cause dehydration, which may lead to a dry mouth—a possible side effect of Stiolto. It is always best to discuss your alcohol consumption with your doctor before starting any new treatment.
Using Stiolto during pregnancy or while breastfeeding should be discussed with your doctor. It is not known if Stiolto will harm an unborn baby or if it passes into breast milk. Your doctor will weigh the potential benefits of using the medication for your COPD against any potential risks to the baby. You should only use Stiolto if clearly needed and prescribed by your healthcare provider.
Stiolto Respimat contains two active ingredients that work together to treat COPD. The first is tiotropium bromide, which is a long-acting muscarinic antagonist (LAMA). The second is olodaterol hydrochloride, a long-acting beta2-adrenergic agonist (LABA). These two bronchodilators help relax the airway muscles in different ways, leading to improved breathing that lasts for 24 hours with a single daily dose.
Your Stiolto Respimat inhaler has a dose indicator that shows approximately how many puffs are left. When the indicator enters the red zone of the scale, it means there is roughly enough medicine for seven days. This is your signal to get a refill. The inhaler will lock automatically and cannot be used anymore once all 60 puffs (or 30 doses) have been administered.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.
Menopause hormone therapy (MHT) is a new term for what used to be called hormone replacement therapy or HRT. If you’ve never heard about menopause hormone therapy, it’s worth remembering that the change of name

You’ve probably seen headlines questioning the safety of GLP-1 medicines – the cornerstone of the wave of the latest drugs that have revolutionized many areas of healthcare, primarily in control of type 2 diabetes and

People whose weight is higher than what is considered healthy for their height are described as having excessive body mass, clinically defined as being overweight or obese. Both of these can increase a person’s risk


